Noll Campbell, PharmD, MS

Contact : campbenl@regenstrief.org

Both over-the-counter and prescription medications impact the lives of older adults in ways doctors, patients and their families may not realize.

Initiatives

Alzheimer’s Disease and Related Dementias

Associate Professor, Department of Pharmacy Practice, Purdue University
Investigator, Center for Aging Research, Regenstrief Institute, Inc.
Scientist, IU Center for Health Innovation and Implementation Science
Faculty Associate, Purdue University Center for Aging and the Life Course

Dr. Noll Campbell’s research is focused on the measurement and management of adverse cognitive effects of medications in older adults with acute and chronic cognitive impairment. This work includes the use of behavioral economic principals to evaluate the impact of deprescribing interventions on clinical and operational outcomes in various care environments.

Dr. Campbell maintains a clinical practice as a geriatric pharmacotherapy expert within Eskenazi Health in Indianapolis, supporting the translation and implementation of his research into clinical care. He was awarded a New Investigator Award from the American Geriatrics Society in 2012, a Hulman Award for Achievement in Geriatrics from the Indiana Public Health Association in 2014, a Departmental Best Paper Award in 2019, and the Chaney Family Early Scholar Award from the Purdue University College of Pharmacy in 2021. His research has received funding through a five-year K23 career development award from the National Institute on Aging in 2014 and a 5-year R01 from the National Institute on Aging in 2019. He served as the 2023-2024 President of the American Delirium Society.

Featured Projects

More Individualized Care: Assessment and Recovery through Engagement (MI-CARE)

(NIH Heal)

Role: Site Co-investigator

To evaluate the impact of a collaborative care program on persistence with OUD treatment programs in adults with OUD and depression.

Delivery of Objective Sleep Evidence (DOSE) Study

(Merck)

Role: Co-Investigator

To develop and validate a passive digital marker for insomnia using electronic medical record data.

OTC Senior Station: A consumer facing technology to improve medication safety in older adults

(Indiana CTSI)

Role: Co-Investigator

To engage in a participatory co-design process to develop a patient-directed tool supporting safe medication purchasing practices in older adults seeking OTC medications.

Highlighted Publications

Feb 5, 2024

An improved statistical modeling approach to analyze individual anticholinergic drug use trends

Publication: IEEE Journal of Biomedical and Health Informatics

doi: 10.1109/JBHI.2023.3332598

Authors: Lou Z, Li M, Kong N, Campbell NL, Tu W

Jan 21, 2024

Home Medication Inventory Method to Assess Over-the-Counter Medication Possession and Use: Feasibility of In-Person and Remote Approaches with Older Adults

Publication: Research in Social and Administrative Pharmacy

doi: 10.1016/j.sapharm.2024.01.005

Authors: Alamer K, Holden RJ, Chui MA, Lee A, Morales L, Campbell NL

Apr 2023

Racial disparities in the Pharmacological Treatment of Insomnia: A Time-to-Event Analysis Using Real-World Data

Publication: Sleep Health

doi: 10.1016/j.sleh.2023.02.002

Authors: Holler E, Campbell NL, Boustani M, Dexter P, Ben Miled Z, Owora A

Jan 1, 2023

Building Demand for Deprescribing Expertise: Pharmacists as Deprescribing Care Coordinators

Publication: The Senior Care Pharmacist

doi: 10.4140/TCP.n.2023.3

Authors: Campbell NL

Jun 2019

Preventing Alzheimer Disease by deprescribing anticholinergic medications

Publication: JAMA Internal Medicine

doi: 10.1001

Authors: Campbell NL, Holden R, Boustani MA

Mar 26, 2021

Multicomponent behavioral intervention to reduce exposure to anticholinergics in primary care older adults

Publication: Journal of the American Geriatrics Society

DOI: 10.1111/jgs.17121

Authors: Campbell NL, Holden RJ, Tang Q, Boustani MA, Teal E, Hillstrom J, Tu W, Clark DO, Callahan CM

May 2021

Reducing Anticholinergic Medication Exposure among Older Adults using Consumer Technology: Protocol for a Randomized Clinical Trial

Publication: Research in Social and Administrative Pharmacy

DOI: 10.1016/j.sapharm.2020.10.010

Authors: Abebe E, Campbell NL, Clark DO, Tu W, Hill JR, Harrington AB, O’Neal G, Trowbridge KS, Vallejo C, Yang Z, Bo N, Knight A, Alamer KA, Carter A, Valenzuela R, Adeoye P, Boustani MA, Holden RJ

Mar 2021